Published in April 2026 issue of Advanced Materials, this breakthrough platform uses patient's own blood to treat severe muscle injuries. Abstract Volumetric muscle loss (VML), a severe injury involving irreversible loss of both muscle tissue and vasculature, poses a major barrier to the development of clinically viable...
Destabilizing DNA repair proteins restores tumor sensitivity to PARP inhibitor therapy. Cancer cells survive by repairing damage to their DNA—even damage that would normally be fatal. One of their most important defense systems is homologous recombination, a high-precision repair pathway that fixes broken DNA using key...
The findings were published in Biosensors and Bioelectronics on March 1, 2026. Mar 16, 2026JooHyeon Heo Public Relations Team print +- Abstract Cancer progression involves cell adhesion molecules (CAMs), which facilitate the recruitment of leukocytes and metastatic tumor cells to distant organs by mediating adhesion with endothelial cells. While CAM-mediated tumor...
ExoDiscovery—built on technology from Professor Yoon-Kyoung Cho’s lab—had its logo showcased on the Nasdaq Tower in Times Square in New York City. Dec 09, 2025JooHyeon Heo Public Relations Team A UNIST faculty startup has secured significant U.S. funding, marking a major milestone in its global commercialization efforts. ExoDiscovery Technologies...
Yoon-Kyoung Cho, Dean of the College of Information and Biotechnology and Professor in the Department of Biomedical Engineering at UNIST, has been officially inaugurated as President of the Chemical and Biological Microsystems Society (CBMS), marking her as the first Korean to hold this position. Recognized globally...
Their findings have been published in Advanced Science on August 21, 2025. Sep 24, 2025JooHyeon Heo Public Relations Team print +- Abstract Reciprocal signaling between metanephric mesenchyme (MM) and ureteric bud (UB) is essential for human kidney development. However, human pluripotent stem cell-derived kidney organoids do not incorporate UB differentiation, limiting...
This study was published in Cancer Research, the official journal of the American Association for Cancer Research (AACR) on August 1, 2025. Sep 22, 2025JooHyeon Heo Public Relations Team print +- Abstract Triggering cancer cell death by inducing DNA damage is the primary aim of radiotherapy; however, normal cells are also...
Vidal Sonics Inc., a biotech startup affiliated with UNIST, has been awarded the Grand Prize at the 2025 R&D Special Zone Tech Startup Investment Competition for S&T Specialized Universities. Sep 15, 2025JooHyeon Heo Public Relations Team print +- Vidal Sonics Inc., a biotech startup affiliated with UNIST, has been awarded...
Professor Jayil Lee and Professor Yoon-Kyoung Cho have been selected for project to develop a global joint research center in advanced biotechnology. Nov 05, 2024JooHyeon Heo Public Relations Team print +- UNIST biomedical engineering researchers are fostering global collaborative research with world-class research institutes. The Ministry of Science and ICT (MSIT) has...
The 2025 Global Symposium on Multiscale Biohybrid Systems took place at UNIST from February 9 to 10, 2025. Feb 13, 2025JooHyeon Heo Public Relations Team print +- As individuals age, muscle regeneration becomes increasingly critical for maintaining health and quality of life. To address this challenge, there is a pressing...
